Factor XII deficiency acquired by orthotopic liver transplantation: Case report and review of the literature

American Journal of Transplantation

Volumn 6, Issue 7, 2006, Pages 1743-1745

  Osborn, N K ^a   Ustundag, Y ^a   Zent, C S ^a   Wiesner, R H ^a   Rosen, C B ^a   Narayanan Menon, K V ^a  

^a MAYO CLINIC   (United States)

Author keywords

Budd Chiari syndrome; Clotting factors; Coagulation; Factor XII deficiency; Hypercoagulable

Indexed keywords

ANTITHROMBIN III; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 12; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; FIBRINOGEN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PHOSPHOLIPID ANTIBODY; PROTEIN C; PROTEIN S; PROTHROMBIN;

ADULT; BLOOD CLOTTING FACTOR 12 DEFICIENCY; BUDD CHIARI SYNDROME; CASE REPORT; DIFFERENTIAL DIAGNOSIS; DISEASE TRANSMISSION; HUMAN; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; ORGAN DONOR; PARTIAL THROMBOPLASTIN TIME; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REVIEW;

DIAGNOSIS, DIFFERENTIAL; FACTOR XII DEFICIENCY; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PARTIAL THROMBOPLASTIN TIME;

EID: 33745356837     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2006.01363.x     Document Type: Review

References (12)

1. Cransac M Carles J Bernard PH et al. Heterozygous protein C deficiency and dysfibrinogenemia acquired by liver. Transpl Int 1995 8: 307 311.
2. Schuetze SM Linenberger M. Acquired protein S deficiency with multiple thrombotic complications after orthotopic liver transplant. Transplantation 1999 67: 1366 1369.
3. Guy SR Magliocca JF Fruchtman S et al. Transmission of factor VII deficiency through liver transplantation. Transpl Int 1999 12: 278 280.
4. Clarkson K Rosenfeld B Fair J Klein A Bell W. Factor XI deficiency acquired by liver transplantation. Ann Intern Med 1991 115: 877 879.
5. Roberts HR Escobar MA. Other clotting factor deficiencies. In: Hoffman, ed. Hematology: Basic Principles and Practice, 4th Ed. Philadelphia, PA, Churchill Livingstone, 2005: 2081 2096.
6. Kitchens CS. The contact system. Arch Pathol Lab Med 2002 126: 1382 1386.
7. Braat EA Dooijewaard G Rijken DC. Fibrinolytic properties of activated FXII. Eur J Biochem 1999 263: 904 911.
8. Halbmayer WM Mannhalter C Feichtinger C Rubi K Fischer M. The prevalence of factor XII deficiency in 103 orally anticoagulated outpatients suffering from recurrent venous and/or arterial thromboembolism. Thromb Haemost 1992 68: 285 290.
9. Goodnough LT Saitoh H Ratnoff OD. Thrombosis or myocardial infarction in congenital clotting factor abnormalities and chronic thrombocytopenias: A report of 21 patients and a review of 50 previously reported cases. Medicine 1983 62: 248 255.
10. Lodi S Isa L Pollini E Bravo AF Scalvini A. Defective intrinsic fibrinolytic activity in a patient with severe factor XII-deficiency and myocardial infarction. Scand J Hematol 1984 33: 80 82.
11. Lammle B Wuillemin WA Huber I et al. Thromboembolism and bleeding tendency in congenital factor XII deficiency - A study on 74 subjects from 14 Swiss families. Thromb Haemost 1991 65: 117 121.
12. Rodeghiero F Castaman G Ruggeri M Tosetto A. Thrombosis in subjects with homozygous and heterozygous factor XII deficiency. Thromb Haemost 1992 67: 590 591.